×

Cookie Settings

We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operations of the website, as well as cookies that are only used for anonymous statistical purposes, for comfort settings or to display personalized content. Please note that based on your settings, it is possible that not all functionalities of the website will be available. You can find further information in our privacy policy.

Please make your personal preference here:

Imprint

 
 
Shopping Cart - CHF 0.00

You have no items in your shopping cart.

  • Home  » 
  • 4033014
Return to Previous Page
4033014

Availability: In stock

(Des-Gly¹⁰,D-Leu⁶,Pro-NHEt⁹)-LHRH acetate salt
Pyr-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt acetate salt

4033014

Product No. Pack Size Available ADS InfoAnalytical Data Sheet List Price Online Order Price Qty
4033014.0005 5 mg Ships within 1 business day ADSExemplary Data Sheet of a current available lot.
CHF 105.00
CHF 97.65 (7%)
4033014.0025 25 mg Ships within 1 business day ADSExemplary Data Sheet of a current available lot.
CHF 420.00
CHF 390.60 (7%)
4033014.0100 100 mg Ships within 1 business day ADSExemplary Data Sheet of a current available lot.
CHF 1,261.00
CHF 1,172.73 (7%)

Details

Leuprolide, a highly active LHRH (GnRH) agonist stimulates the pituitary release of luteinizing hormone, causing an increase in testicular androgen production. Thus, leuprolide represents a safer alternative to estrogens, and may be preferred in the treatment of men with advanced prostate cancer. CAS Number (net): 53714-56-0.
Catalog Number H-4060
APC Number 54-1-22
Synonyms Leuprolide, Leuprorelin, [Des-Gly10, DLeu6, Pro9] LH-RH, Ethyl Amide
Molecular Formula C₅₉H₈₄N₁₆O₁₂
Relative Molecular Mass 1209.42
CAS Registry Number 74381-53-6
Source Synthetic
Storage Conditions -20 ± 5 °C
Keywords LHRH agonist
Application Cancer Research
Pituitary & Hypothalamic Hormones
Veterinary Medicine
Links / Documents:
Brochures:

Bachem product citations

M.Rahimi et al., Int. J. Polymeric Materials and Polymeric Biomaterials, (2015)
S.D'Souza et al., Advances in Pharmaceutics, 2015, 12 (2015)
R.Mashayekhi et al., Daru, 21, 57 (2013)
L.C.Herrera et al., Dissolution Technologies, 19, (2012)
A.Schoubben et al., J. Pharm. Sci., 101, 1212 (2012)
P.Podhorec et al., Gen. Comp. Endocrinol., 175, 34 (2012)
S.Dunnhaupt et al., Carbohydr. Polym., 90, 765 (2012)
J.J.Haynes et al., Bioanalysis, 3, 763 (2011)
D.K.Laimou et al., Amino Acids, 39, 1147 (2010)
R.Astaneh et al., J. Pharm. Sci., 98, 135 (2009)
N.Bahmanyar et al., Iran Polymer. J., 17, 345 (2008)
Z.D.Sofianos et al., J. Mass Spectrom., 43, 1381 (2008)
R.Astaneh et al., DARU Journal of Pharmaceutical Sciences, 65 (2006)
S.S.D'Souza and P.P.DeLuca, AAPS PharmSciTech, 6, E323 (2005)
S.S.D'Souza and P.P.DeLuca, AAPS PharmSciTech, 6, E323 (2005)
S.S.D'Souza et al., AAPS PharmSciTech, 6, E553 (2005)
C.Kochhar and G.Imanidis, J. Pharm. Sci., 92, 84 (2003)
D.H.Na et al., J. Control. Release, 92, 291 (2003)
H.B.Ravivarapu et al., J. Pharm. Sci., 89, 732 (2000)
H.B.Ravivarapu et al., AAPS PharmSciTech, 1, E1 (2000)
M.Shameem et al., AAPS PharmSci., 1, E7 (1999)

Product citations

Merck Index, 15th ed., No. 5509, (2013)
D.Levine et al., J. Reprod. Med., 52, 581 (2007)
E.Castellón et al., Cancer Invest., 24, 261 (2006)
A.Imai et al., Int. J. Oncol., 20, 987 (2002)
J.D.Meyer et al., J. Pept. Res., 60, 159 (2002)
T.Mizutani et al., Int. J. Fertil. Menopaus. Stud., 40, 106 (1995)
P.Chrisp and E.M.Sorkin, Drugs & Aging, 1, 487 (1991)
A.S.Dutta, Drugs Future, 13, 43 (1988)
D.H.Coy and A.V.Schally, Ann. Clin. Res., 10, 139 (1978)
Related products